about
Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsEpigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3.Cell mediators of autoimmune hepatitis and their therapeutic implications.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Galectin-3 in autoimmunity and autoimmune diseases.Human autoimmune diseases: a comprehensive update.Evolving paradigm of treatment for autoimmune hepatitis.Pleurotus nebrodensis polysaccharide(PN50G) evokes A549 cell apoptosis by the ROS/AMPK/PI3K/AKT/mTOR pathway to suppress tumor growth.Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Low-grade elevation of fibrinogen-degradation products is an important parameter to identify acute presentation of autoimmune hepatitis.Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis.Decreased serum DNase1-activity in patients with autoimmune liver diseases.Role of ultrasound and microbubble-mediated heat shock protein 72 siRNA on ischemia-reperfusion liver injury in rat.Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitisClearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis.Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease.Salidroside mediates apoptosis and autophagy inhibition in concanavalin A-induced liver injury.Quantitative Proteomic Analysis Reveals That Arctigenin Alleviates Concanavalin A-Induced Hepatitis Through Suppressing Immune System and Regulating Autophagy
P2860
Q28076505-887229D6-974C-44D9-B69A-19A503D4D9F5Q36598500-1F776F57-AC99-4FE9-BFC8-F72B81E94C98Q38285331-AC974107-4155-478A-9005-BDE46CBE600EQ38496935-951F3AEF-4BFA-4632-8F6A-FD762BBC4C30Q38542678-3C5FAC63-D02D-411E-B476-E97D86869972Q38554722-3BA76D04-FB39-41D5-859D-3DFAE36E7AD9Q38730872-9A873CEF-C770-4993-AB50-1A3A7D382AF7Q38790829-9739AF9D-1A2A-41EF-B9E1-90E1A22EE1E2Q38895458-730642AE-F484-4063-B27A-28F96913F5A1Q38902371-ABF1FC01-6DBD-41EA-92D9-B2448E1B1DB4Q39780824-85528DF1-8A64-4B7F-821F-0CB2E5DE868CQ40044046-6C82950A-3A97-41AE-B3FA-9DA3E8724336Q40306774-E2E9D5FF-B4DD-4D27-9DBA-68AC05B87B20Q41641505-5F1A485A-AC60-42C8-9A52-FA15F24923D4Q42369219-E6B65DD5-2A2D-4780-B4E1-5CFA0CC2162BQ49691927-BA9CF023-02B7-41A1-8E66-ED973AD3C9A1Q53093579-A7082602-9557-4C91-A902-6A4D9DECA996Q54978043-129F7311-9189-4A03-8114-C0AD08784C06Q58773456-F72D5952-B8EF-4C10-9D52-3A8563388154
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting apoptosis in autoimmune hepatitis.
@en
type
label
Targeting apoptosis in autoimmune hepatitis.
@en
prefLabel
Targeting apoptosis in autoimmune hepatitis.
@en
P2860
P1476
Targeting apoptosis in autoimmune hepatitis.
@en
P2093
Albert J Czaja
P2860
P2888
P304
P356
10.1007/S10620-014-3284-2
P577
2014-07-20T00:00:00Z
P6179
1016765415